Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v2.4.0.8
Condensed Consolidated Balance Sheets (Unaudited) (USD $)
Jun. 30, 2013
Dec. 31, 2012
CURRENT ASSETS:    
Cash    $ 20
Prepaid expenses    7,500
Total Current Assets    7,520
Total Assets    7,520
CURRENT LIABILITIES:    
Accounts payable and accrued expenses 535,889 492,766
Accounts payable - related party 1,138,922 849,170
Derivative liabilities 49,396 50,888
Convertible notes payable, net of debt discounts 237,132 210,110
Liabilities for discontinued operations 112,397 112,397
Total Current Liabilities 2,073,736 1,715,331
Commitments and Contingencies      
STOCKHOLDERS' DEFICIT:    
Preferred stock, $0.0001 par value; 10,000,000 authorized Series A, 3,000,000 issued and outstanding Series B, none issued and outstanding Series C, none issued and outstanding Series D, 1,000,000 issued and outstanding 400 400
Common stock; $0.0001 par value; 750,000,000 shares authorized; 253,033,555 shares issued and outstanding 25,303 25,303
Additional paid-in capital 47,859,648 47,859,648
Accumulated deficit (41,947,270) (41,947,270)
Accumulated deficit since inception of exploration stage (April 25, 2011) (8,011,817) (7,645,892)
Total Stockholders' Deficit (2,073,736) (1,707,811)
Total Liabilities and Stockholders' Deficit    7,520
Preferred Stock - Series A
    
STOCKHOLDERS' DEFICIT:    
Preferred stock, $0.0001 par value; 10,000,000 authorized Series A, 3,000,000 issued and outstanding Series B, none issued and outstanding Series C, none issued and outstanding Series D, 1,000,000 issued and outstanding 300 300
Total Stockholders' Deficit 300 300
Preferred Stock - Series D
    
STOCKHOLDERS' DEFICIT:    
Preferred stock, $0.0001 par value; 10,000,000 authorized Series A, 3,000,000 issued and outstanding Series B, none issued and outstanding Series C, none issued and outstanding Series D, 1,000,000 issued and outstanding 100 100
Total Stockholders' Deficit $ 100 $ 100